News & Perspective

Feb 08, 2019

Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Jan 09, 2019

Jan 09, 2019
Doctor prescribing using electronic tablet

Study sheds more light on delamanid role in treating MDR-TB

Safety profile was good, and sensitivity analysis favored delamanid as part of MDR-TB treatment.

Nov 02, 2018

Nov 02, 2018

News Scan for Nov 02, 2018

Polio in 4 countries
Avian flu in Minnesota, Vietnam
Testing for very resistant TB
New CWD type in moose?

Oct 19, 2018

Oct 19, 2018

Stewardship / Resistance Scan for Oct 19, 2018

Undetected MDR-TB in South Africa
Carbapenem prescribing algorithm

Sep 27, 2018

Sep 27, 2018
DNA test genetic sequencing

Study heralds genetic era of TB drug susceptibility testing

Whole-genome sequencing could lead to faster, more accurate resistance testing.

Sep 18, 2018

Sep 18, 2018
Mycobacterium tuberculosis bacteria

WHO report warns efforts to end TB are falling short

TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.

Sep 07, 2018

Sep 07, 2018
Capsules and syringe

Study provides data behind new MDR-TB guidance

Newer and repurposed drugs produced better results and fewer deaths than older treatments did.

Aug 27, 2018

Aug 27, 2018

Stewardship / Resistance Scan for Aug 27, 2018

Bedaquiline for MDR-TB
Australian stewardship study

Aug 21, 2018

Aug 21, 2018

Stewardship / Resistance Scan for Aug 21, 2018

Antibiotics for kids' UTIs
Drug-resistant TB surveillance model

Aug 20, 2018

Aug 20, 2018
MDR-TB detection

WHO revises MDR-TB treatment with focus on oral drugs

The changes prioritize newer medications and oral regimens over injectable drugs.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»